Eagle Pharmaceuticals saw the highest growth of 0.99% in patent filings and 2.99% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.49% and grants by 0.99%. GlobalData’s DataBook provides a comprehensive analysis of Eagle Pharmaceuticals‘s patent filings and grants. Buy the databook here.
Eagle Pharmaceuticals has been focused on protecting inventions in United States(US) with three publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 33% filings and 29% grants. The United States(US), South Korea(KR), Australia(AU), and Israel(IL) patent Office are among the top ten patent offices where Eagle Pharmaceuticals is filings its patents. Among the top granted patent authorities, Eagle Pharmaceuticals has 29% of its grants in United States(US), 29% in Israel(IL) and 14% in South Korea(KR).
Roche and Johnson & Johnson could be the strongest competitors for Eagle Pharmaceuticals
Patents related to climate change and rare diseases lead Eagle Pharmaceuticals's portfolio
Eagle Pharmaceuticals has the highest number of patents in climate change followed by, rare diseases. For climate change no patents were filed and 50% of patents were granted in Q2 2024.
Manufacturing/industrial related patents lead Eagle Pharmaceuticals portfolio followed by emesis (vomiting), and post operative nausea and vomiting
Eagle Pharmaceuticals has highest number of patents in manufacturing/industrial followed by emesis (vomiting), post operative nausea and vomiting, nausea. For manufacturing/industrial, nearly 33% of patents were filed and 44% of patents were granted in Q2 2024.
For comprehensive analysis of Eagle Pharmaceuticals's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.